Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Gastrointestinal Bleeding Treatment Devices Market Size Forecast: How Big Could The Market Get By 2030?#_x000D_
The market for gastrointestinal bleeding treatment devices has experienced robust expansion in recent years. It is projected to expand from $0.92 billion in 2025 to $1 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. Historically, this growth has been fueled by factors such as the increasing occurrence of gastrointestinal disorders, the growing prevalence of peptic ulcer disease, the broader implementation of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the presence of sophisticated endoscopy equipment._x000D_
_x000D_
The gastrointestinal bleeding treatment devices market is projected to experience substantial expansion in the coming years, reaching $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is fueled by factors such as the heightened uptake of next-generation endoscopic devices, an escalating demand for outpatient GI procedures, a sharpened emphasis on detecting bleeding early, the proliferation of ambulatory surgical centers, and increased capital flow into advanced GI care technologies. Key developments expected in this period encompass the greater integration of sophisticated endoscopic hemostasis devices, an uptick in the application of minimally invasive GI bleeding treatments, a surging need for accurate thermal ablation tools, the broadening availability of mechanical hemostatic solutions, and an intensified drive towards rapid bleeding management technologies._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Gastrointestinal Bleeding Treatment Devices Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The increasing burden of gastrointestinal disorders is anticipated to make the market more profitable. These diseases can stem from various factors, including a low fiber diet, stress, insufficient water intake, high consumption of dairy foods, inactive lifestyles, aging, and genetic predispositions. For instance, a report from October 2024 by the US-based National Library of Medicine indicated that in 2023, 825 per 100,000 Canadians were afflicted with inflammatory bowel disease (IBD), impacting over 320,000 individuals. Furthermore, forecasts suggest this count might increase to 1.1% of the population, roughly 470,000 Canadians, by 2035. Consequently, the growing prevalence of disorders related to the GI tract is a significant market driver._x000D_
_x000D_
#Gastrointestinal Bleeding Treatment Devices Market Segments: Where Is Growth Concentrated?#_x000D_
The gastrointestinal bleeding treatment devices market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices_x000D_
2) By GI Tract Division: Upper GI Tract, Lower GI Tract_x000D_
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users_x000D_
_x000D_
Subsegments:_x000D_
1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices_x000D_
2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices_x000D_
3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems_x000D_
4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents_x000D_
5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms_x000D_
_x000D_
#Gastrointestinal Bleeding Treatment Devices Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Leading companies in the gastrointestinal bleeding treatment devices market are prioritizing the creation of advanced solutions like Hemospray, aiming to boost the effectiveness of treating acute bleeding within the GI tract. Hemospray itself is a hemostatic powder crafted to manage and control active gastrointestinal bleeding. For example, in January 2024, AIG Hospitals, an India-based medical institution, launched Hemospray, hailing it as a breakthrough in regulating GI bleeding. This particular hemostatic agent is specifically engineered for deployment in endoscopic procedures to control acute GI bleeding. Hemospray stands out due to its simple application, robust safety record, and its proven capability to halt various types of GI bleeds, encompassing conditions from peptic ulcers to variceal hemorrhages._x000D_
_x000D_
#Gastrointestinal Bleeding Treatment Devices Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC _x000D_
_x000D_
#View The Full Gastrointestinal Bleeding Treatment Devices Market Report:#_x000D_
_x000D_
#Gastrointestinal Bleeding Treatment Devices Market Global Footprint: Which Region Leads The Market?#_x000D_
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
